Necrotic enteritis also called as necrotizing enterocolitis is inflammatory bowel disease found prematurely born infants.
This report contains market size and forecasts of Necrotic Enteritis Drug in Global, including the following market information:
Global Necrotic Enteritis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Necrotic Enteritis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inter Alpha Inhibitor Proteins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Necrotic Enteritis Drug include Prometic Life Sciences, BioGaia Probiotics, Fresenius, Teva, Bayer, Alcon and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Necrotic Enteritis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Necrotic Enteritis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Necrotic Enteritis Drug Market Segment Percentages, by Type, 2021 (%)
Inter Alpha Inhibitor Proteins
Antibiotics
Global Necrotic Enteritis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Necrotic Enteritis Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Necrotic Enteritis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Necrotic Enteritis Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Necrotic Enteritis Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Necrotic Enteritis Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Prometic Life Sciences
BioGaia Probiotics
Fresenius
Teva
Bayer
Alcon
GlaxoSmithKline